A Study of PHST001 in Advanced Solid Tumors
Public ClinicalTrials.gov record NCT06840886. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Phase 1a/1b, Dose Escalation and Dose Expansion Study Investigating the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of PHST001 in Adult Patients With Advanced Relapsed and/or Refractory Solid Tumors
Study identification
- NCT ID
- NCT06840886
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Pheast Therapeutics
- Industry
- Enrollment
- 272 participants
Conditions and interventions
Interventions
- Chemotherapy per Standard of Care Drug
- PHST001 Biological
Drug · Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 30, 2025
- Primary completion
- Mar 31, 2029
- Completion
- Mar 31, 2031
- Last update posted
- Apr 21, 2026
2025 – 2031
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Precision NextGen Oncology & Research Center | Beverly Hills | California | 90212 | Not yet recruiting |
| USC Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | Recruiting |
| Stanford University School of Medicine | Palo Alto | California | 94304 | Recruiting |
| Sarah Cannon Research Institute (SCRI) Oncology Partners - Denver Health One | Denver | Colorado | 80218 | Recruiting |
| Yale Cancer Center | New Haven | Connecticut | 06520 | Recruiting |
| University of Chicago Medical Center | Chicago | Illinois | 60637 | Recruiting |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | Recruiting |
| University of Michigan Rogel Cancer Center | Ann Arbor | Michigan | 48109 | Recruiting |
| START Center for Cancer Research - Midwest | Grand Rapids | Michigan | 49546 | Recruiting |
| START Center for Cancer Research - Long Island New York | Lake Success | New York | 11042 | Recruiting |
| Mount Sinai | New York | New York | 10029 | Not yet recruiting |
| Duke Cancer Institute | Durham | North Carolina | 27710 | Recruiting |
| Sarah Cannon Research Institute (SCRI) Oncology Partners | Nashville | Tennessee | 37203 | Recruiting |
| Vanderbilt-Ingram Cancer Center | Nashville | Tennessee | 37203 | Recruiting |
| START Center for Cancer Research - Texas | Fort Worth | Texas | 76104 | Recruiting |
| MD Anderson Cancer Center | Houston | Texas | 77030 | Recruiting |
| NEXT Oncology - Dallas | Irving | Texas | 75039 | Recruiting |
| South Texas Accelerated Research Therapeutics (START) | San Antonio | Texas | 78229 | Recruiting |
| University of Texas (UT) Health | San Antonio | Texas | 78229 | Not yet recruiting |
| NEXT Oncology - Virginia | Fairfax | Virginia | 22031 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06840886, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 21, 2026 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06840886 live on ClinicalTrials.gov.